JPS56140921A - Use of 5-alkylpyrimidine nucleoside as cell stationary agent and virus stationary agent - Google Patents

Use of 5-alkylpyrimidine nucleoside as cell stationary agent and virus stationary agent

Info

Publication number
JPS56140921A
JPS56140921A JP3642881A JP3642881A JPS56140921A JP S56140921 A JPS56140921 A JP S56140921A JP 3642881 A JP3642881 A JP 3642881A JP 3642881 A JP3642881 A JP 3642881A JP S56140921 A JPS56140921 A JP S56140921A
Authority
JP
Japan
Prior art keywords
stationary agent
alkylpyrimidine
nucleoside
virus
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3642881A
Other languages
Japanese (ja)
Inventor
Kumaaru Gauri Kairatsushiyu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Robugen GmbH
Original Assignee
Robugen GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robugen GmbH filed Critical Robugen GmbH
Publication of JPS56140921A publication Critical patent/JPS56140921A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
JP3642881A 1980-03-18 1981-03-12 Use of 5-alkylpyrimidine nucleoside as cell stationary agent and virus stationary agent Pending JPS56140921A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803010397 DE3010397A1 (en) 1980-03-18 1980-03-18 USE OF 5-ALKYL-PYRIMIDINE NUCLEOSIDES AS A CYTOSTATIKA

Publications (1)

Publication Number Publication Date
JPS56140921A true JPS56140921A (en) 1981-11-04

Family

ID=6097574

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3642881A Pending JPS56140921A (en) 1980-03-18 1981-03-12 Use of 5-alkylpyrimidine nucleoside as cell stationary agent and virus stationary agent

Country Status (4)

Country Link
JP (1) JPS56140921A (en)
CA (1) CA1162853A (en)
CH (1) CH655934A5 (en)
DE (1) DE3010397A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152898A (en) * 1982-03-08 1983-09-10 Taiho Yakuhin Kogyo Kk 2'-deoxy-5-trifluoromethyluridine derivative, its preparation and antitumor agent containing the same

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
ATA173599A (en) * 1999-10-14 2001-04-15 Lilly Co Eli PHARMACEUTICAL PRODUCT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152898A (en) * 1982-03-08 1983-09-10 Taiho Yakuhin Kogyo Kk 2'-deoxy-5-trifluoromethyluridine derivative, its preparation and antitumor agent containing the same

Also Published As

Publication number Publication date
DE3010397A1 (en) 1981-10-29
CA1162853A (en) 1984-02-28
CH655934A5 (en) 1986-05-30

Similar Documents

Publication Publication Date Title
GB2059436B (en) Propagation of cells
IL68491A0 (en) Manufacture and expression of large structural genes
JPS549289A (en) Novel dihydropyridazone compound*its preparation and curative agent containing same
GB2064523B (en) Stable composition of s-adenosyl-l-methionine
JPS5495789A (en) Propagation of rota virus
JPS54101432A (en) Detoxication of cell propagation controlling agent
GR62851B (en) Superoxidated solid perborate sodium and preparation process thereof
JPS5579148A (en) Combined piece of lumber and polymer
IL58147A (en) Preparation of alkylthiomethylphenols and arylthiomethylphenols
NZ187683A (en) Injectible compositions containing chloramphenicol and pvp
JPS56140921A (en) Use of 5-alkylpyrimidine nucleoside as cell stationary agent and virus stationary agent
JPS5444672A (en) Manufacture of benzotriazole and benzotriazoleennoxide
JPS5523491A (en) Cell and ion cell of passing type
JPS5522370A (en) Carrying device of solid agent
JPS53137998A (en) Composition of substance and method
JPS533928A (en) Platingginhibiting agent and method of using same
GB2062468B (en) Stable solutions of hydrogenated ergotalkaloids and heparin
ZA786815B (en) Electrochemical cell and the protection of an electrochemical cell
EP0094514A3 (en) Designation of footnotes and footnote references
JPS53108902A (en) Composition of substance and method
JPS5543085A (en) Aminomethylcyclododecanes*their manufacture and their use as corrosionnpreventing agent
PH12781A (en) Antihypertensive compositions and method of use thereof
JPS5522369A (en) Carrying device of solid agent
JPS5563652A (en) Blood purifying method and purifying agent
GB2079273B (en) Preparation of 1-hydropentadecafluoro-adamantane and perfluoroadamantane